ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Adorial Pharma Ltd

Adorial Pharma Ltd is a dissolved company incorporated on 15 December 2014 with the registered office located in Manchester, Greater Manchester. Adorial Pharma Ltd was registered 11 years ago.
Status
Dissolved
Dissolved on 20 January 2026 (3 days ago)
Was 11 years old at the time of dissolution
Via voluntary strike-off
Company No
09355532
Private limited company
Age
11 years
Incorporated 15 December 2014
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 3 December 2025 (1 month ago)
Next confirmation dated 1 January 1970
Last change occurred 9 years ago
Accounts
Not Submitted
Awaiting first accounts
Contact
Address
Part Ground Floor Broadhurst House
56 Oxford Street
Manchester
M1 6EU
United Kingdom
Address changed on 25 Mar 2025 (9 months ago)
Previous address was Part Ground Floor Broadhurst House 58 Oxford Street Manchester M1 6EU England
Telephone
Unreported
Email
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in UK • Born in Jul 1965
Director • British • Lives in UK • Born in Jan 1978
Adorial Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
C4X Discovery Limited
Emma Blaney is a mutual person.
Active
C4X Discovery Holdings Limited
Emma Blaney is a mutual person.
Active
C4X Drug Discovery Limited
Nicholas Ray and Emma Blaney are mutual people.
Dissolved
Adorial Ltd
Nicholas Ray and Emma Blaney are mutual people.
Dissolved
Adorial Technologies Ltd
Nicholas Ray and Emma Blaney are mutual people.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Jul31 Dec 2024
Traded for 17 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£0
Same as previous period
Total Liabilities
-£4.99K
Same as previous period
Net Assets
-£4.99K
Same as previous period
Debt Ratio (%)
Unreported
Latest Activity
Voluntarily Dissolution
3 Days Ago on 20 Jan 2026
Confirmation Submitted
1 Month Ago on 4 Dec 2025
Voluntary Gazette Notice
2 Months Ago on 4 Nov 2025
Application To Strike Off
2 Months Ago on 27 Oct 2025
Full Accounts Submitted
4 Months Ago on 18 Sep 2025
Registered Address Changed
9 Months Ago on 25 Mar 2025
Registered Address Changed
10 Months Ago on 13 Mar 2025
Accounting Period Extended
10 Months Ago on 11 Mar 2025
Mrs Emma Blaney Appointed
10 Months Ago on 26 Feb 2025
Mr Nicholas Ray Appointed
10 Months Ago on 26 Feb 2025
Get Credit Report
Discover Adorial Pharma Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 20 Jan 2026
Confirmation statement made on 3 December 2025 with no updates
Submitted on 4 Dec 2025
First Gazette notice for voluntary strike-off
Submitted on 4 Nov 2025
Application to strike the company off the register
Submitted on 27 Oct 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 18 Sep 2025
Registered office address changed from Part Ground Floor Broadhurst House 58 Oxford Street Manchester M1 6EU England to Part Ground Floor Broadhurst House 56 Oxford Street Manchester M1 6EU on 25 March 2025
Submitted on 25 Mar 2025
Registered office address changed from Manchester One 53 Portland Street Manchester M1 3LD England to Part Ground Floor Broadhurst House 58 Oxford Street Manchester M1 6EU on 13 March 2025
Submitted on 13 Mar 2025
Previous accounting period extended from 31 July 2024 to 31 December 2024
Submitted on 11 Mar 2025
Appointment of Mrs Emma Blaney as a director on 26 February 2025
Submitted on 3 Mar 2025
Appointment of Mr Nicholas Ray as a director on 26 February 2025
Submitted on 3 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year